Ionis Pharmaceuticals (IONS) Earnings Date, Estimates & Call Transcripts $42.36 +0.85 (+2.05%) (As of 05:18 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 7EstimatedActual EPS (Aug. 1) -$0.45 Beat By $0.47 Consensus EPS (Aug. 1) -$0.92 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Get Ionis Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for IONS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIONS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IONS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… Ionis Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.85)($0.72)($0.80) Q2 20243($1.05)($0.74)($0.87) Q3 20243($1.04)($0.92)($0.98) Q4 20243($1.15)($0.57)($0.77) FY 202412($4.09)($2.95)($3.42) Q1 20251($1.13)($1.13)($1.13) Q2 20251($0.95)($0.95)($0.95) Q3 20251($0.93)($0.93)($0.93) IONS Earnings Date and InformationIonis Pharmaceuticals last released its quarterly earnings results on August 1st, 2024. The reported ($0.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.92) by $0.47. The firm earned $225 million during the quarter, compared to the consensus estimate of $152.35 million. Its revenue was up 19.7% on a year-over-year basis. Ionis Pharmaceuticals has generated ($2.67) earnings per share over the last year (($2.67) diluted earnings per share). Earnings for Ionis Pharmaceuticals are expected to grow in the coming year, from ($3.68) to ($3.59) per share. Ionis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off prior year's report dates.Read More Ionis Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/7/2024(Estimated)------- 8/1/2024Q2 2024($0.92)($0.45)+$0.47($0.45)$152.35 million$225.00 million 5/7/2024Q1 2024($1.10)($0.98)+$0.12($0.98)$131.42 million$119.00 million 2/21/2024Q4 2023($0.78)($0.06)+$0.72($0.06)$176.01 million$325.00 million 11/2/2023Q3 2023($1.01)($1.03)($0.02)($1.03)$139.42 million$144.00 million 8/9/2023Q2 2023($0.94)$0.60+$1.54$0.60$136.84 million$188.00 million 5/3/2023Q1 2023($1.00)($0.87)+$0.13($0.87)$126.88 million$131.00 million Get the Latest News and Ratings for IONS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ionis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/22/2023Q4 2022($1.06)($0.37)+$0.69($0.37)$160.21 million$152.00 million 11/9/2022Q3 2022($0.74)($0.33)+$0.41($0.33)$149.48 million$160.00 million 8/9/2022Q2 2022($0.61)($0.74)($0.13)($0.74)$142.65 million$134.00 million 5/4/2022Q1 2022($0.68)($0.46)+$0.22($0.46)$122.46 million$142.00 million 2/24/2022Q4 2021$0.80$1.41+$0.61$1.41$284.08 million$440.00 million 11/3/2021Q3 2021($0.53)($0.58)($0.05)($0.58)$162.01 million$133.00 million 8/4/2021Q2 2021($0.56)($0.57)($0.01)($0.57)$128.46 million$126.00 million 5/5/2021Q1 2021($0.48)($0.64)($0.16)($0.64)$134.93 million$112.00 million 2/24/2021Q4 2020$0.24($2.44)($2.68)($2.44)$265.93 million$290.00 million 11/4/2020Q3 2020($0.11)($0.22)($0.11)($0.22)$182.14 million$160.00 million 8/5/2020Q2 2020($0.28)($0.23)+$0.05($0.23)$148.87 million$146.00 million 5/6/2020Q1 2020($0.12)($0.35)($0.23)$0.15$161.59 million$133.00 million 2/26/2020Q4 2019$0.91$1.28+$0.37$1.28$407.05 million$494.00 million 11/6/2019Q3($0.31)$0.18+$0.49$0.18$152.47 million$168.00 million Ionis Pharmaceuticals Earnings - Frequently Asked Questions When is Ionis Pharmaceuticals's earnings date? Ionis Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates. Learn more on IONS's earnings history. What guidance has Ionis Pharmaceuticals issued on next quarter's earnings? Ionis Pharmaceuticals issued an update on its FY 2024 earnings guidance on Thursday, August, 1st. The company issued revenue guidance of $575.0 million-, compared to the consensus revenue estimate of $608.7 million. Did Ionis Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Ionis Pharmaceuticals (NASDAQ:IONS) reported ($0.45) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.92) by $0.47. Learn more on analysts' earnings estimate vs. IONS's actual earnings. How can I listen to Ionis Pharmaceuticals's earnings conference call? The conference call for Ionis Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Ionis Pharmaceuticals's conference call transcript? The conference call transcript for Ionis Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Ionis Pharmaceuticals generate each year? Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded annual revenue of $813.46 million. How much profit does Ionis Pharmaceuticals generate each year? Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded net income of -$366.29 million. IONS has generated -$2.67 earnings per share over the last four quarters. What is Ionis Pharmaceuticals's EPS forecast for next year? Ionis Pharmaceuticals's earnings are expected to grow from ($3.68) per share to ($3.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies: JAZZ Earnings Date RARE Earnings Date PRGO Earnings Date BHVN Earnings Date ACAD Earnings Date ARWR Earnings Date BHC Earnings Date BMRN Earnings Date UTHR Earnings Date INCY Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:IONS) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredCrypto ‘Banana Zone’ Incoming…What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ionis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IONS Stock Alerts